1. Jaggi TK, Agarwal R, Tiew PY, et al. Fungal lung disease. Eur Respir J 2024; 64: 2400803 [DOI: 10.1183/13993003.00803-2024].
2. Xia Y, Jiang W, Zhu X, et al. Global, Regional, and National Burden of Pulmonary Fungal Infections 1990–2021. Am J Respir Crit Care Med 2015; 211: 1007-1017.
3. Denning DW, Chakrabarti A. Pulmonary and sinus fungal diseases in non-immunocompromised patients. Lancet Infect Dis 2017, 17:e357-e366.
4. Azar M. A Diagnostic Approach to Fungal Pneumonia. An Infectious Diseases Perspective. Chest 2024; 165:559-572.
5. Thompson GR, Young JAH. Aspergillus Infections Ne Engl J Med 2021; 385:1496-509.
6. Jaggi TK, Ter SK, Aogain M, Chotirmall SH. Aspergillus-Associated Endophenotypes in Bronchiectasis. Semin Respir Crit Care Med 2021;42:556–566.
7. Brown JS, Armstrong-James D, Ayling-Smith J, et al. British Thoracic Society Clinical Statement on Aspergillus- related chronic lung disease. Thorax 2025;80(suppl 1):3–21. doi:10.1136/
thorax-2024-222567.
8. Jiang C, Dai J, Bao Y, et al. Surgical Treatment of Pulmonary Aspergilloma: A 13- year Experience From a Single Clinical Center. Ann Thorac Surg 2022;114:311–8.
9. Tamkeviciute L, Tumenas A, Zaveckiene J, Irion K, Franquet T, Radika M. Different forms of pulmonary aspergillosis: A pictorial essay. Eur J Radiol 2024; 171:111290
10. Ullmann AJ, Aguada JM, Arikan-Akdagli S, etal. Diagnosis and management of Aspergillusdiseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect
2018; 24 Suppl 1: e1-e38
11. Alastruey-Izquierdo A, Cadranel J, Flick H, et al. Treatment of Chronic Pulmonary Aspergillosis: Current Standards and Future Perspectives. Respiration 2018; 96: 159-170
12. Heylen J, Vanbiervliet Y, Maertens J, Rijnders B, Wauters J. Acute Invasive Pulmonary Aspergillosis: Clinical Presentation and Treatment. Semin Respir Crit Care Med 2024; 45:69-87
13. Pergram SA. Fungal Pneumonia in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation. Clin Chest Med 2017; 38: 279-294.
14. Bays DJ, Thompson GR. Fungal Infections of the Stem Cell recipient and Hematologic malignancy Patients. Infect Dis Clin N Am 2019; 33: 545-566.
15. Wahab A, Sanborn D, Vergidis P, Razonable R, Yadav H, Pennington KM. Diagnosis and Prevention of Invasive Fungal Infections in the Immunocompromised Host. Chest 2025; 167: 374-386.
16. Epelbaum O, Marinelli T, Haydour Q, et al. Treatment of Invasive Pulmonary Aspergillosis and Preventive and Empirical Therapy for Invasive Candidiasis in Adult Pulmonary and Critical
Care Patients An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med 2025;211: 34-53.
17. Zhang Z and Wang M. Three case reports of pulmonary mucormycosis with a review of the literature. Front Med 2015; 12:1580912.
18. Alamo L, Ceppi F, Tenisch E, Beigelman-Aubry C. CT imaging findings of invasive pulmonary fungal infections in hemato-oncologic children. Insights into Imaging 2024; 296
19. Yi H, Zhang S, Wang J, et al. CT Features for Prognostic Assessment of Pulmonary Mucormycosis in Patients With Hematological Diseases. J Thorac Imaging 2025;40:e0832
20. Liu J, Yu L, Ma X, et al. Clinical Characteristics, Radiological, and Outcomes of Mucormycosis: A 14- Year Retrospective Study From Southern China. Mycoses, 2025; 68:e70110
21. Cartagena AJ, Asowata AE, Ng D, Babady NE. An overview of the laboratory diagnosis of Pneumocystis jirovecii pneumonia. J Clin Microbiol 2025; 63:10.1128/jcm.00361-24
22. Shaddock E. Pneumocystis jirovecii: A Fresh Look. Clin Pulm Med 2016;23:37–43
23. Challener GJ, Labban ME, Kanj AN, et al. Pneumocystis jirovecii Pneumonia in Patients Without HIV, Transplant, or Cancer: Missed Opportunities for Prevention. JCR: Journal of Clinical
Rheumatology 2025; 10.1097/RHU.0000000000002279.
24. Reizine F, Stiegler V, Lecuyer R, et al. Respiratory management of critically ill pneumocystis pneumonia patients: a multicenter retrospective study. Annals of Intensive Care 2025; 15:114
25. Shi Y, Chen R, Sun H, et al. Characteristics and prognostic analysis of Pneumocystis jirovecii pneumonia in connective tissue diseases patients with interstitial lung disease: a retrospective study.
Clinical Rheumatology 2025; 44:1653–1663
26. Costa VS, Cidade JP, Medeiros I, et al. Pneumocystis jirovecii Pneumonia Diagnosis with Oropharyngeal Wash PCR in Immunocompromised Patients—A Systematic Review. J. Clin. Med.
2025, 14,6572.
27. Zhang L, Zheng C, Sun Y, et al. Diagnostic tests performance in detecting Pneumocystis jirovecii: A systematic review and meta-analysis. European J of Clin Microbiol & Infectious Dis 2025;
44:789–805
28. Xin L, Jiao X, Gong X, et al. Diagnostic value of metagenomic next generation sequencing of bronchoalveolar lavage fluid in immunocompromised patients with pneumonia. Front Cell Infect
Microbiol 2025, 15:1602636